Professional Documents
Culture Documents
Anxiety Disorders
Anxiety Disorders
Anxiety Disorders
Anxiety disorders are common psychiatric disorders. Many patients with anxiety disorders experience physical
symptoms related to anxiety and subsequently visit their primary care physicians. Despite the high prevalence rates
of these anxiety disorders, they often are underrecognized and undertreated clinical problems. (слайд 1)The
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) classifies the anxiety disorders into
the following categories:
• (слайд 2) In the US: Two major studies in the United States have estimated the prevalence rates for a
variety of anxiety disorders. These 2 studies are the Epidemiological Catchment Area (ECA) study and the
National Comorbidity Survey (NCS) study. Using these and other studies, the estimated lifetime prevalence
rates for individual anxiety disorders are panic disorder (2.3-2.7%), generalized anxiety disorder (4.1-6.6%),
obsessive-compulsive disorder (2.3-2.6%), posttraumatic stress disorder (1-9.3%), and social phobia (2.6-
13.3%).
• Internationally: The prevalence of specific anxiety disorders appears to vary between countries and
cultures. A cross-national study of the prevalence of panic disorder found lifetime prevalence rates ranging
from 0.4% in Taiwan to 2.9% in Italy. A cross-cultural study of the prevalence of OCD found lifetime
prevalence rates ranging from 0.7% in Taiwan to 2.5% in Puerto Rico.
Severe anxiety disorders may be complicated by suicide, with or without secondary mood disorders (eg,
depression). Anxiety disorders have high rates of comorbidity with major depression and alcohol and drug
abuse. Chronic anxiety may be associated with increased risk for cardiovascular morbidity and mortality.
The female-to-male ratio for any lifetime anxiety disorder is 3:2. Most anxiety disorders begin in childhood,
adolescence, and early adulthood. Separation anxiety is an anxiety disorder of childhood that often includes
anxiety related to going to school. This disorder may be a precursor for adult anxiety disorders. Panic disorder
demonstrates a bimodal age of onset in the NCS study in the age groups of 15-24 years and 45-54 years. The
median age of onset of social phobia in the NCS study was 16 years. The age of onset for OCD appears to be in
the mid 20s to early 30s.
• (слайд 3) Panic disorder is characterized by recurrent panic attacks (ie, periods of intense fear of abrupt
2
onset peaking in intensity within 10 min). Four of the following must be present for a panic attack:
o Paresthesias
• (слайд 4) Generalized anxiety disorder is characterized by excessive anxiety and worry. Worrying is difficult
to control. Anxiety and worry are associated with at least 3 of the following symptoms:
o Avoidance behavior, anticipation, or distress in the feared social or performance setting produces
significant impairment in functioning
• (слайд 7) Posttraumatic stress disorder is a severe trauma that is experienced that includes (1) actual or
threatened death or serious injury or threat to personal integrity of self or others and (2) responses that
include intense fear, helplessness, or horror.
Anxiety disorders have one of the longest differential diagnosis lists of all psychiatric disorders. Anxiety is a
nonspecific syndrome and can be due to a variety of medical or psychiatric syndromes. A variety of anxiety
symptoms, such as panic, worry, rumination, and obsessions, can present in a variety of psychiatric illnesses
including mood disorders, psychotic disorders, personality disorders, somatoform disorders, and cognitive
impairment disorders (eg, delirium). Anxiety also can be observed as part of a drug withdrawal or drug intoxication
effect.
Consultations:
• In anxiety disorders secondary to a general medical condition, specialty consultation may be indicated.
Selective serotonin reuptake inhibitors (SSRIs) are helpful in a variety of anxiety disorders, including generalized
anxiety disorder, panic disorder, OCD, and social phobia.
Antidepressant agents are the drugs of choice in the treatment of anxiety disorders, particularly the newer agents
that have a safer adverse effect profile and higher ease of use than the older tricyclic agents; however,
benzodiazepines often are used as adjunct treatment.
Some anticonvulsant medications, such as divalproex and gabapentin, may have a role in the treatment of anxiety
disorders, especially in patients with high potential for abusing benzodiazepines.
Older antidepressants, such as tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) also are
effective in the treatment of some anxiety disorders. Caution in their use is warranted due to their higher toxicity and
potential lethality in overdose. Their use should be limited to cases where SSRIs are ineffective or cannot be
afforded. MAOIs may be especially indicated in treatment-refractory panic disorder. Clomipramine (Anafranil, a
tricyclic agent) has a US Food and Drug Administration (FDA) indication in the treatment of OCD and is the only
tricyclic agent effective in the treatment of this condition. Indeed, it can be effective in cases refractory to treatment
with SSRI agents. MAOI agents also may have a role in the treatment of certain subtypes of OCD refractory to
conventional treatment, such as patients with symmetry obsessions or associated panic attacks.
Benzodiazepines are especially useful in the management of acute situational anxiety disorder and adjustment
disorder where the duration of pharmacotherapy is anticipated to be 6 weeks or less and for the rapid control of
panic attacks. If long-term use of benzodiazepines seems necessary, obtaining a confirmatory opinion from a
second physician may be helpful because chronic benzodiazepine use may be associated with tolerance,
withdrawal, and treatment-emergent anxiety.
• Inpatient care rarely is needed for the management of anxiety disorders unless complicated by comorbid
5
• Inpatient care should be considered if suicide is a risk or detoxification is needed for comorbid substance
dependence.
• Anxiety disorders often are chronic and require ongoing medical/psychiatric care, including psychosocial
therapies and medication (pharmacotherapy).
o Cognitive-behavioral therapy often is efficacious and is the treatment of choice for specific phobias. It often
is used alone or in combination with pharmacotherapy in the treatment of OCD and panic disorder.
o Other psychotherapeutic approaches, such as interpersonal therapy or psychodynamic therapy, also may
be helpful in the treatment of anxiety disorders.
o Marital therapy, family therapy, or group therapy may be helpful adjunct therapies in the long-term
management of severe anxiety disorders.
Prognosis:
• Anxiety disorders can range from mild and transient to severe and chronic.
• Early treatment improves prognosis and limits social and occupational impairment.